Comment by
GoldenInvestor on Jul 07, 2022 9:24pm
WOW! & we are making money & new drugs launched! GI
Comment by
gudisgood on Jul 08, 2022 5:32am
Interesting, the buybacks have effectively stopped? I hope that's a sign of there being an attractive acquisition target. Perhaps they've found even better uses for the money. :)
Comment by
EbbFlow88 on Jul 08, 2022 7:29am
The current NCIB should be maxed out by now as they were able to buy and cancel 10.6M shares. That expires around July 12-13, so we should see next week that they are renewing the NCIB for 2022.
Comment by
Catscratch on Jul 11, 2022 12:32pm
There are also been sizable insider buying over the past couple of years. A lot of stock is either getting bought/cancelled or landing in long term accounts (insiders, Armoyan, smart value funds etc.) At some point the sellers aren't going to have any stock left and the share price should move higher.